 | • レポートコード：D005-00838 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、前立腺がん診断及び治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。前立腺がん診断及び治療の種類別市場規模（前立腺特異抗原検査（PSA）、直腸指診（DRE））、用途別市場規模（病院、診断クリニック、研究センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Laboratories、Bayer、Amgen、AbbVie、Bavarian Nordic、Active Biotech、Dendreon、AstraZeneca、Astellas Pharma、Bristol-Myers Squibb、Ipsen、Sanofi、Endo、Takeda、Johnson & Johnson、GSK、Ferring Pharmaceuticals、Siemens Healthineers、Pfizer、GE Healthcare、Teva Pharmaceutical、Tolmar Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・前立腺がん診断及び治療の北米市場（アメリカ、カナダ、メキシコ） ・前立腺がん診断及び治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・前立腺がん診断及び治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・前立腺がん診断及び治療の南米市場（ブラジル、アルゼンチン） ・前立腺がん診断及び治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：前立腺特異抗原検査（PSA）、直腸指診（DRE） ・用途別分析：病院、診断クリニック、研究センター ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Prostate Cancer Diagnosis and Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Prostate Cancer Diagnosis and Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Prostate Cancer Diagnosis and Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Prostate Cancer Diagnosis and Treatment market has been segmented into:
Prostate specific antigen test (PSA)
Digital rectal exam (DRE)
By Application, Prostate Cancer Diagnosis and Treatment has been segmented into:
Hospitals
Diagnostic clinics
Research centers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Prostate Cancer Diagnosis and Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Prostate Cancer Diagnosis and Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prostate Cancer Diagnosis and Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Prostate Cancer Diagnosis and Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Prostate Cancer Diagnosis and Treatment Market Share Analysis
Prostate Cancer Diagnosis and Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prostate Cancer Diagnosis and Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prostate Cancer Diagnosis and Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Prostate Cancer Diagnosis and Treatment are:
Abbott Laboratories
Bayer
Amgen
AbbVie
Bavarian Nordic
Active Biotech
Dendreon
AstraZeneca
Astellas Pharma
Bristol-Myers Squibb
Ipsen
Sanofi
Endo
Takeda
Johnson & Johnson
GSK
Ferring Pharmaceuticals
Siemens Healthineers
Pfizer
GE Healthcare
Teva Pharmaceutical
Tolmar Pharmaceuticals
Table of Contents
1 Prostate Cancer Diagnosis and Treatment Market Overview
1.1 Product Overview and Scope of Prostate Cancer Diagnosis and Treatment
1.2 Classification of Prostate Cancer Diagnosis and Treatment by Type
1.2.1 Global Prostate Cancer Diagnosis and Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type in 2019
1.2.3 Prostate specific antigen test (PSA)
1.2.4 Digital rectal exam (DRE)
1.3 Global Prostate Cancer Diagnosis and Treatment Market by Application
1.3.1 Overview: Global Prostate Cancer Diagnosis and Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Diagnostic clinics
1.3.4 Research centers
1.4 Global Prostate Cancer Diagnosis and Treatment Market by Regions
1.4.1 Global Prostate Cancer Diagnosis and Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Prostate Cancer Diagnosis and Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Prostate Cancer Diagnosis and Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Prostate Cancer Diagnosis and Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prostate Cancer Diagnosis and Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Prostate Cancer Diagnosis and Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prostate Cancer Diagnosis and Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bayer SWOT Analysis
2.2.4 Bayer Product and Services
2.2.5 Bayer Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amgen SWOT Analysis
2.3.4 Amgen Product and Services
2.3.5 Amgen Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AbbVie SWOT Analysis
2.4.4 AbbVie Product and Services
2.4.5 AbbVie Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bavarian Nordic
2.5.1 Bavarian Nordic Details
2.5.2 Bavarian Nordic Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bavarian Nordic SWOT Analysis
2.5.4 Bavarian Nordic Product and Services
2.5.5 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Active Biotech
2.6.1 Active Biotech Details
2.6.2 Active Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Active Biotech SWOT Analysis
2.6.4 Active Biotech Product and Services
2.6.5 Active Biotech Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Dendreon
2.7.1 Dendreon Details
2.7.2 Dendreon Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Dendreon SWOT Analysis
2.7.4 Dendreon Product and Services
2.7.5 Dendreon Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca SWOT Analysis
2.8.4 AstraZeneca Product and Services
2.8.5 AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Astellas Pharma
2.9.1 Astellas Pharma Details
2.9.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Astellas Pharma SWOT Analysis
2.9.4 Astellas Pharma Product and Services
2.9.5 Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bristol-Myers Squibb
2.10.1 Bristol-Myers Squibb Details
2.10.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bristol-Myers Squibb SWOT Analysis
2.10.4 Bristol-Myers Squibb Product and Services
2.10.5 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Ipsen
2.11.1 Ipsen Details
2.11.2 Ipsen Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Ipsen SWOT Analysis
2.11.4 Ipsen Product and Services
2.11.5 Ipsen Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sanofi
2.12.1 Sanofi Details
2.12.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sanofi SWOT Analysis
2.12.4 Sanofi Product and Services
2.12.5 Sanofi Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 Endo
2.13.1 Endo Details
2.13.2 Endo Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Endo SWOT Analysis
2.13.4 Endo Product and Services
2.13.5 Endo Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.14 Takeda
2.14.1 Takeda Details
2.14.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Takeda SWOT Analysis
2.14.4 Takeda Product and Services
2.14.5 Takeda Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.15 Johnson & Johnson
2.15.1 Johnson & Johnson Details
2.15.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Johnson & Johnson SWOT Analysis
2.15.4 Johnson & Johnson Product and Services
2.15.5 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.16 GSK
2.16.1 GSK Details
2.16.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 GSK SWOT Analysis
2.16.4 GSK Product and Services
2.16.5 GSK Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.17 Ferring Pharmaceuticals
2.17.1 Ferring Pharmaceuticals Details
2.17.2 Ferring Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Ferring Pharmaceuticals SWOT Analysis
2.17.4 Ferring Pharmaceuticals Product and Services
2.17.5 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.18 Siemens Healthineers
2.18.1 Siemens Healthineers Details
2.18.2 Siemens Healthineers Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Siemens Healthineers SWOT Analysis
2.18.4 Siemens Healthineers Product and Services
2.18.3 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.19 Pfizer
2.19.1 Pfizer Details
2.19.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Pfizer SWOT Analysis
2.19.4 Pfizer Product and Services
2.19.5 Pfizer Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.20 GE Healthcare
2.20.1 GE Healthcare Details
2.20.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 GE Healthcare SWOT Analysis
2.20.4 GE Healthcare Product and Services
2.20.5 GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.21 Teva Pharmaceutical
2.21.1 Teva Pharmaceutical Details
2.21.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Teva Pharmaceutical SWOT Analysis
2.21.4 Teva Pharmaceutical Product and Services
2.21.5 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.22 Tolmar Pharmaceuticals
3 Market Competition, by Players
3.1 Global Prostate Cancer Diagnosis and Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Prostate Cancer Diagnosis and Treatment Players Market Share
3.2.2 Top 10 Prostate Cancer Diagnosis and Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Prostate Cancer Diagnosis and Treatment Revenue and Market Share by Regions
4.2 North America Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
5 North America Prostate Cancer Diagnosis and Treatment Revenue by Countries
5.1 North America Prostate Cancer Diagnosis and Treatment Revenue by Countries (2015-2020)
5.2 USA Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
6 Europe Prostate Cancer Diagnosis and Treatment Revenue by Countries
6.1 Europe Prostate Cancer Diagnosis and Treatment Revenue by Countries (2015-2020)
6.2 Germany Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
6.4 France Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue by Countries
7.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue by Countries (2015-2020)
7.2 China Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
7.5 India Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
8 South America Prostate Cancer Diagnosis and Treatment Revenue by Countries
8.1 South America Prostate Cancer Diagnosis and Treatment Revenue by Countries (2015-2020)
8.2 Brazil Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Prostate Cancer Diagnosis and Treatment by Countries
9.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Prostate Cancer Diagnosis and Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Prostate Cancer Diagnosis and Treatment Market Forecast by Type (2019-2024)
10.3 Prostate specific antigen test (PSA) Revenue Growth Rate (2015-2025)
10.4 Digital rectal exam (DRE) Revenue Growth Rate (2015-2025)
11 Global Prostate Cancer Diagnosis and Treatment Market Segment by Application
11.1 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Application (2015-2020)
11.2 Prostate Cancer Diagnosis and Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Diagnostic clinics Revenue Growth (2015-2020)
11.5 Research centers Revenue Growth (2015-2020)
12 Global Prostate Cancer Diagnosis and Treatment Market Size Forecast (2021-2025)
12.1 Global Prostate Cancer Diagnosis and Treatment Market Size Forecast (2021-2025)
12.2 Global Prostate Cancer Diagnosis and Treatment Market Forecast by Regions (2021-2025)
12.3 North America Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2021-2025)
12.6 South America Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Prostate Cancer Diagnosis and Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Prostate Cancer Diagnosis and Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Prostate Cancer Diagnosis and Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories Corporate Information, Location and Competitors
Table 6. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Major Business
Table 7. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories SWOT Analysis
Table 9. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 10. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bayer Corporate Information, Location and Competitors
Table 12. Bayer Prostate Cancer Diagnosis and Treatment Major Business
Table 13. Bayer Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Bayer SWOT Analysis
Table 15. Bayer Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 16. Bayer Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Amgen Corporate Information, Location and Competitors
Table 18. Amgen Prostate Cancer Diagnosis and Treatment Major Business
Table 19. Amgen Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Amgen SWOT Analysis
Table 21. Amgen Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 22. Amgen Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. AbbVie Corporate Information, Location and Competitors
Table 24. AbbVie Prostate Cancer Diagnosis and Treatment Major Business
Table 25. AbbVie Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 26. AbbVie SWOT Analysis
Table 27. AbbVie Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 28. AbbVie Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Bavarian Nordic Corporate Information, Location and Competitors
Table 30. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Major Business
Table 31. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Bavarian Nordic SWOT Analysis
Table 33. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 34. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Active Biotech Corporate Information, Location and Competitors
Table 36. Active Biotech Prostate Cancer Diagnosis and Treatment Major Business
Table 37. Active Biotech Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Active Biotech SWOT Analysis
Table 39. Active Biotech Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 40. Active Biotech Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Dendreon Corporate Information, Location and Competitors
Table 42. Dendreon Prostate Cancer Diagnosis and Treatment Major Business
Table 43. Dendreon Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Dendreon SWOT Analysis
Table 45. Dendreon Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 46. Dendreon Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. AstraZeneca Corporate Information, Location and Competitors
Table 48. AstraZeneca Prostate Cancer Diagnosis and Treatment Major Business
Table 49. AstraZeneca Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 50. AstraZeneca SWOT Analysis
Table 51. AstraZeneca Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 52. AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Astellas Pharma Corporate Information, Location and Competitors
Table 54. Astellas Pharma Prostate Cancer Diagnosis and Treatment Major Business
Table 55. Astellas Pharma Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Astellas Pharma SWOT Analysis
Table 57. Astellas Pharma Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 58. Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 60. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Major Business
Table 61. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Bristol-Myers Squibb SWOT Analysis
Table 63. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 64. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Ipsen Corporate Information, Location and Competitors
Table 66. Ipsen Prostate Cancer Diagnosis and Treatment Major Business
Table 67. Ipsen Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 68. Ipsen SWOT Analysis
Table 69. Ipsen Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 70. Ipsen Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Sanofi Corporate Information, Location and Competitors
Table 72. Sanofi Prostate Cancer Diagnosis and Treatment Major Business
Table 73. Sanofi Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 74. Sanofi SWOT Analysis
Table 75. Sanofi Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 76. Sanofi Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Endo Corporate Information, Location and Competitors
Table 78. Endo Prostate Cancer Diagnosis and Treatment Major Business
Table 79. Endo Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 80. Endo SWOT Analysis
Table 81. Endo Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 82. Endo Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Takeda Corporate Information, Location and Competitors
Table 84. Takeda Prostate Cancer Diagnosis and Treatment Major Business
Table 85. Takeda Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 86. Takeda SWOT Analysis
Table 87. Takeda Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 88. Takeda Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Johnson & Johnson Corporate Information, Location and Competitors
Table 90. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Major Business
Table 91. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 92. Johnson & Johnson SWOT Analysis
Table 93. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 94. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. GSK Corporate Information, Location and Competitors
Table 96. GSK Prostate Cancer Diagnosis and Treatment Major Business
Table 97. GSK Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 98. GSK SWOT Analysis
Table 99. GSK Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 100. GSK Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Ferring Pharmaceuticals Corporate Information, Location and Competitors
Table 102. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Major Business
Table 103. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 104. Ferring Pharmaceuticals SWOT Analysis
Table 105. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 106. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Type and Application
Table 108. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Major Business
Table 109. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 110. Siemens Healthineers SWOT Analysis
Table 111. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 112. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Pfizer Corporate Information, Location and Competitors
Table 114. Pfizer Prostate Cancer Diagnosis and Treatment Major Business
Table 115. Pfizer Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 116. Pfizer SWOT Analysis
Table 117. Pfizer Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 118. Pfizer Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. GE Healthcare Corporate Information, Location and Competitors
Table 120. GE Healthcare Prostate Cancer Diagnosis and Treatment Major Business
Table 121. GE Healthcare Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 122. GE Healthcare SWOT Analysis
Table 123. GE Healthcare Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 124. GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Teva Pharmaceutical Corporate Information, Location and Competitors
Table 126. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Major Business
Table 127. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 128. Teva Pharmaceutical SWOT Analysis
Table 129. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 130. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 131. Tolmar Pharmaceuticals Corporate Information, Location and Competitors
Table 132. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Major Business
Table 133. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Total Revenue (USD Million) (2017-2018)
Table 134. Tolmar Pharmaceuticals SWOT Analysis
Table 135. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product and Solutions
Table 136. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 137. Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Players (2015-2020)
Table 138. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Players (2015-2020)
Table 139. Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Regions (2015-2020)
Table 140. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Regions (2015-2020)
Table 141. North America Prostate Cancer Diagnosis and Treatment Revenue by Countries (2015-2020)
Table 142. North America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Table 143. Europe Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Countries (2015-2020)
Table 144. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Countries (2015-2020)
Table 145. South America Prostate Cancer Diagnosis and Treatment Revenue by Countries (2015-2020)
Table 146. South America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Table 147. Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Countries (2015-2020)
Table 148. Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Table 149. Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) by Type (2015-2020)
Table 150. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Type (2015-2020)
Table 151. Global Prostate Cancer Diagnosis and Treatment Revenue Forecast by Type (2021-2025)
Table 152. Global Prostate Cancer Diagnosis and Treatment Revenue by Application (2015-2020)
Table 153. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Application (2015-2020)
Table 154. Global Prostate Cancer Diagnosis and Treatment Revenue Forecast by Application (2021-2025)
Table 155. Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Prostate Cancer Diagnosis and Treatment Picture
Figure 2. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type in 2019
Figure 3. Prostate specific antigen test (PSA) Picture
Figure 4. Digital rectal exam (DRE) Picture
Figure 5. Prostate Cancer Diagnosis and Treatment Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Diagnostic clinics Picture
Figure 8. Research centers Picture
Figure 9. Global Prostate Cancer Diagnosis and Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Prostate Cancer Diagnosis and Treatment Revenue Market Share in 2019
Figure 18. Global Top 10 Players Prostate Cancer Diagnosis and Treatment Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Regions (2015-2020)
Figure 22. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Regions in 2018
Figure 23. North America Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 24. Europe Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 26. South America Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 28. North America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Figure 29. North America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries in 2019
Figure 30. USA Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Canada Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Europe Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries in 2019
Figure 35. Germany Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 36. UK Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 37. France Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Russia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Italy Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries in 2019
Figure 42. China Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Japan Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Korea Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 45. India Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 47. South America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Figure 48. South America Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries in 2019
Figure 49. Brazil Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 54. UAE Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Type (2015-2020)
Figure 58. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Type in 2019
Figure 59. Global Prostate Cancer Diagnosis and Treatment Market Share Forecast by Type (2021-2025)
Figure 60. Global Prostate specific antigen test (PSA) Revenue Growth Rate (2015-2020)
Figure 61. Global Digital rectal exam (DRE) Revenue Growth Rate (2015-2020)
Figure 62. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Application (2015-2020)
Figure 63. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Application in 2019
Figure 64. Global Prostate Cancer Diagnosis and Treatment Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 66. Global Diagnostic clinics Revenue Growth Rate (2015-2020)
Figure 67. Global Research centers Revenue Growth Rate (2015-2020)
Figure 68. Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Prostate Cancer Diagnosis and Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2021-2025)
Figure 72. Europe Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2021-2025)
Figure 74. South America Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
前立腺がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Prostate Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prostate Cancer Tre…- 去勢抵抗性前立腺がん（CRPC）/ HRPCA治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.9% in the forecast period of 2020 to 2025 and will expected to reach USD 9300.5 million by 2025, from USD 7…
- 前立腺特異抗原（PSA）テストの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Prostate-Specific Antigen (PSA) Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prostate…
- 前立腺がん診断の世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Prostate Cancer Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.0% in the forecast period of 2020 to 2025 and will expected to reach USD 15640 million by 2025, from USD 11940 million in 2019. The Pr…
- 前立腺がんデバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Prostate Cancer Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prostate Canc…